AC Immune SA - Stock Price History | ACIU

Historical daily share price chart and data for AC Immune SA since 2021 adjusted for splits. The latest closing stock price for AC Immune SA as of September 24, 2021 is 6.91.
  • The all-time high AC Immune SA stock closing price was 19.30 on September 28, 2016.
  • The AC Immune SA 52-week high stock price is 12.61, which is 82.5% above the current share price.
  • The AC Immune SA 52-week low stock price is 4.42, which is 36% below the current share price.
  • The average AC Immune SA stock price for the last 52 weeks is 6.54.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
AC Immune SA Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 6.8312 8.6600 9.8900 4.2400 5.1700 -39.32%
2019 5.8668 10.2200 11.6800 3.6500 8.5200 -9.84%
2018 10.3710 13.3500 16.4550 7.3500 9.4500 -26.17%
2017 10.4581 13.0100 13.6600 6.7000 12.8000 -1.39%
2016 14.1403 15.6600 19.3000 10.5200 12.9800 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.509B $0.016B
AC Immune SA is a biopharmaceutical company. It develops, discover and design novel, proprietary medicines for prevention, diagnosis and treatment of neurodegenerative diseases. The Company's pipeline includes Crenezumab, ACI-24, Anti-Tau antibody, Morphomer Tau, Tau-PET imaging agent, Morphomer Abeta and Morphomer alpha-syn which are in clinical trial. AC Immune SA is based in Lausanne, Switzerland.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71